Shape complementarity at protein/protein interfaces - PubMed (original) (raw)
. 1993 Dec 20;234(4):946-50.
doi: 10.1006/jmbi.1993.1648.
Affiliations
- PMID: 8263940
- DOI: 10.1006/jmbi.1993.1648
Shape complementarity at protein/protein interfaces
M C Lawrence et al. J Mol Biol. 1993.
Abstract
A new statistic Sc, which has a number of advantages over other measures of packing, is used to examine the shape complementarity of protein/protein interfaces selected from the Brookhaven Protein Data Bank. It is shown using Sc that antibody/antigen interfaces as a whole exhibit poorer shape complementarity than is observed in other systems involving protein/protein interactions. This result can be understood in terms of the fundamentally different evolutionary history of particular antibody/antigen associations compared to other systems considered, and in terms of the differing chemical natures of the interfaces.
Similar articles
- Electrostatic complementarity at protein/protein interfaces.
McCoy AJ, Chandana Epa V, Colman PM. McCoy AJ, et al. J Mol Biol. 1997 May 2;268(2):570-84. doi: 10.1006/jmbi.1997.0987. J Mol Biol. 1997. PMID: 9159491 - Examination of shape complementarity in docking of unbound proteins.
Norel R, Petrey D, Wolfson HJ, Nussinov R. Norel R, et al. Proteins. 1999 Aug 15;36(3):307-17. Proteins. 1999. PMID: 10409824 - Does structural and chemical divergence play a role in precluding undesirable protein interactions?
Jiménez JL. Jiménez JL. Proteins. 2005 Jun 1;59(4):757-64. doi: 10.1002/prot.20448. Proteins. 2005. PMID: 15822102 - Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
Fan ZC, Shan L, Goldsteen BZ, Guddat LW, Thakur A, Landolfi NF, Co MS, Vasquez M, Queen C, Ramsland PA, Edmundson AB. Fan ZC, et al. J Mol Recognit. 1999 Jan-Feb;12(1):19-32. doi: 10.1002/(SICI)1099-1352(199901/02)12:1<19::AID-JMR445>3.0.CO;2-Y. J Mol Recognit. 1999. PMID: 10398393 Review. - Cyclosporin A as a model antigen: immunochemical and structural studies.
Altschuh D. Altschuh D. J Mol Recognit. 2002 Sep-Oct;15(5):277-85. doi: 10.1002/jmr.588. J Mol Recognit. 2002. PMID: 12447904 Review.
Cited by
- The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4.
Moradi S, Berry R, Pymm P, Hitchen C, Beckham SA, Wilce MC, Walpole NG, Clements CS, Reid HH, Perugini MA, Brooks AG, Rossjohn J, Vivian JP. Moradi S, et al. J Biol Chem. 2015 Apr 17;290(16):10460-71. doi: 10.1074/jbc.M114.612291. Epub 2015 Mar 10. J Biol Chem. 2015. PMID: 25759384 Free PMC article. - Structural insights for engineering binding proteins based on non-antibody scaffolds.
Gilbreth RN, Koide S. Gilbreth RN, et al. Curr Opin Struct Biol. 2012 Aug;22(4):413-20. doi: 10.1016/j.sbi.2012.06.001. Epub 2012 Jun 27. Curr Opin Struct Biol. 2012. PMID: 22749196 Free PMC article. Review. - Control of repeat-protein curvature by computational protein design.
Park K, Shen BW, Parmeggiani F, Huang PS, Stoddard BL, Baker D. Park K, et al. Nat Struct Mol Biol. 2015 Feb;22(2):167-74. doi: 10.1038/nsmb.2938. Epub 2015 Jan 12. Nat Struct Mol Biol. 2015. PMID: 25580576 Free PMC article. - Structural studies of cerebral cavernous malformations 2 (CCM2) reveal a folded helical domain at its C-terminus.
Fisher OS, Zhang R, Li X, Murphy JW, Demeler B, Boggon TJ. Fisher OS, et al. FEBS Lett. 2013 Jan 31;587(3):272-7. doi: 10.1016/j.febslet.2012.12.011. Epub 2012 Dec 22. FEBS Lett. 2013. PMID: 23266514 Free PMC article. - Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein.
Chen E, Salinas ND, Huang Y, Ntumngia F, Plasencia MD, Gross ML, Adams JH, Tolia NH. Chen E, et al. Proc Natl Acad Sci U S A. 2016 May 31;113(22):6277-82. doi: 10.1073/pnas.1600488113. Epub 2016 May 18. Proc Natl Acad Sci U S A. 2016. PMID: 27194724 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources